BACTERICIDAL ACTIVITIES OF TEICOPLANIN, VANCOMYCIN, AND GENTAMICIN ALONE AND IN COMBINATION AGAINST STAPHYLOCOCCUS-AUREUS IN AN IN-VITRO PHARMACODYNAMIC MODEL OF ENDOCARDITIS

被引:50
作者
MCGRATH, BJ
KANG, SL
KAATZ, GW
RYBAK, MJ
机构
[1] DETROIT RECEIVING HOSP UNIV HLTH CTR, DEPT PHARM SERV, ANTIINFECT RES LAB, DETROIT, MI 48201 USA
[2] WAYNE STATE UNIV, COLL PHARM & ALLIED HLTH PROFESS, DETROIT, MI 48202 USA
[3] WAYNE STATE UNIV, SCH MED, DEPT INTERNAL MED, DIV INFECT DIS, DETROIT, MI 48201 USA
关键词
D O I
10.1128/AAC.38.9.2034
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We adapted an in vitro pharmacodynamic model of infection to incorporate simulated endocardial vegetations. The bactericidal activities of teicoplanin, vancomycin, gentamicin, and various combinations of these drugs were studied against a strain of methicillin-susceptible Staphylococcus aureus obtained from a patient being treated for endocarditis at Detroit Receiving Hospital. Bacteria were grown overnight, concentrated, and added to a mixture of cryoprecipitate (80%) and thrombin (10%) to achieve approximately 5 x 10(9) CFU/g. Fibrin clots (8 to 10) were suspended into the model, removed at 24, 48, and 72 h in duplicate, weighed, and homogenized in 1.25% trypsin. Control experiments were conducted to characterize the growth kinetics. The following antibiotics were administered to simulate the pharmacokinetics of the drugs in humans: teicoplanin at 3 and 15 mg/kg of body weight, vancomycin at 15 mg/kg, and gentamicin at 1 mg/kg. Fibrin clot samples used to detect resistance were plated on antibiotic containing tryptic soy agar plates. For the teicoplanin and vancomycin regimens, protein binding to cryoprecipitate, thrombin, and fibrin clot was determined to be 32, 43, and 50% and 26, 28, and 29%, respectively. In comparison with no treatment, vancomycin or teicoplanin at 15 mg/kg or either of these regimens combined with gentamicin significantly reduced bacterial counts (P < 0.0001). Monotherapy with teicoplanin at 3 mg/kg or gentamicin resulted in no killing activity. Combination treatment with teicoplanin at 3 mg/kg and gentamicin resulted in the killing of approximately 2 log(10) CFU/g by 72 h and the development of resistance to gentamicin. The results obtained ,vith the in vitro model of endocarditis are similar to the results reported by several investigators with the rabbit model of infective endocarditis. This unique infection model is useful for designing initial drug dosage regimens and may be predictive of drug efficacy against infective endocarditis.
引用
收藏
页码:2034 / 2040
页数:7
相关论文
共 44 条
[1]   COMPARATIVE EFFECT OF PROTEIN-BINDING ON THE KILLING ACTIVITIES OF TEICOPLANIN AND VANCOMYCIN [J].
BAILEY, EM ;
RYBAK, MJ ;
KAATZ, GW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1089-1092
[2]   PENETRATION OF ANTIBIOTICS INTO FIBRIN LOCI IN-VIVO .3. INTERMITTENT VS CONTINUOUS INFUSION AND EFFECT OF PROBENECID [J].
BARZA, M ;
BRUSCH, J ;
BERGERON, MG ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (01) :73-78
[3]   PENETRATION OF ANTIBIOTICS INTO FIBRIN LOCI IN-VIVO .1. COMPARISON OF PENETRATION OF AMPICILLIN INTO FIBRIN CLOTS, ABSCESSES, AND INTERSTITIAL FLUID [J].
BARZA, M ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (01) :59-65
[4]   INFECTIVE ENDOCARDITIS [J].
BAYER, AS .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (03) :313-320
[6]   PENETRATION OF CEFAMANDOLE, CEPHALOTHIN, AND DESACETYLCEPHALOTHIN INTO FIBRIN CLOTS [J].
BERGERON, MG ;
NGUYEN, BM ;
TROTTIER, S ;
GAUVREAU, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (06) :682-687
[7]   PHARMACODYNAMICS OF ANTIBIOTICS IN FIBRIN CLOTS [J].
BERGERON, MG ;
ROBERT, J ;
BEAUCHAMP, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :113-136
[8]   CLINICAL-EVALUATION OF EFFICACY, PHARMACOKINETICS, AND SAFETY OF TEICOPLANIN FOR SERIOUS GRAM-POSITIVE INFECTIONS [J].
BIBLER, MR ;
FRAME, PT ;
HAGLER, DN ;
BODE, RB ;
STANECK, JL ;
THAMLIKITKUL, V ;
HARRIS, JE ;
HAREGEWOIN, A ;
BULLOCK, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) :207-212
[9]  
BLASER J, 1985, J ANTIMICROB CHEMOTH, V25, P57
[10]   EARLY TERMINATION OF A PROSPECTIVE, RANDOMIZED TRIAL COMPARING TEICOPLANIN AND FLUCLOXACILLIN FOR TREATING SEVERE STAPHYLOCOCCAL INFECTIONS [J].
CALAIN, P ;
KRAUSE, KH ;
VAUDAUX, P ;
AUCKENTHALER, R ;
LEW, D ;
WALDVOGEL, F ;
HIRSCHEL, B .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (02) :187-191